Nipro Corporation

8086.T
Medical Instruments & Supplies
2026/03/02 Updated
Market Cap: $1.7B (¥259.4B)
Stock Price: $10.18 (¥1,591)
Exchange Rate: 1 USD = ¥156.25

Notice Regarding Establishment of the Nomination and Remuneration Committee

Effective April 1, 2026, Nipro Corporation will establish a 'Nomination and Remuneration Committee' with added authority over director nominations to enhance corporate governance.

Importance:
Page Updated: February 25, 2026
IR Disclosure Date: February 25, 2026

Key Figures

  • Establishment Date: 2026年4月1日
  • Committee Composition: At least 3 directors, majority are independent outside directors
  • Committee Role: Appointment and dismissal of directors, selection and removal of representative directors, matters concerning remuneration

AI要約

Purpose and Role of the Nomination and Remuneration Committee

Nipro Corporation has resolved to establish, effective April 1, 2026, a 'Nomination and Remuneration Committee' as an advisory body to the Board of Directors by adding authority over director nominations to the existing Remuneration Committee. The objective is to ensure fairness, transparency, and objectivity in procedures concerning director nominations and remuneration, thereby strengthening corporate governance. The committee discusses and reports on matters such as appointment and dismissal of directors, selection and removal of representative directors, selection and removal of executive directors, remuneration-related matters, and succession planning in response to inquiries from the Board of Directors.

Committee Composition and Establishment Date

The Nomination and Remuneration Committee is composed of three or more directors selected by resolution of the Board of Directors, with a majority appointed from independent outside directors. The chairperson is elected from among the committee members by the committee's resolution. The establishment date is April 1, 2026, and this is expected to further enhance the transparency and objectivity of the decision-making process regarding director nominations and remuneration.

This page uses AI to summarize IR materials from TDnet. Please refer to the original document for investment decisions.